Review



soluble anti mouse cd28  (Biogems International)


Bioz Verified Symbol Biogems International is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Biogems International soluble anti mouse cd28
    Soluble Anti Mouse Cd28, supplied by Biogems International, used in various techniques. Bioz Stars score: 93/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/soluble anti mouse cd28/product/Biogems International
    Average 93 stars, based on 8 article reviews
    soluble anti mouse cd28 - by Bioz Stars, 2026-06
    93/100 stars

    Images



    Similar Products

    97
    Bio X Cell soluble anti cd28
    Soluble Anti Cd28, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/soluble anti cd28/product/Bio X Cell
    Average 97 stars, based on 1 article reviews
    soluble anti cd28 - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    93
    Biogems International soluble anti mouse cd28
    Soluble Anti Mouse Cd28, supplied by Biogems International, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/soluble anti mouse cd28/product/Biogems International
    Average 93 stars, based on 1 article reviews
    soluble anti mouse cd28 - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    97
    Bio X Cell soluble anti mouse cd28
    Tumor cell C/EBPβ increases CTLA-4 expression in CD4 + T cells. (A) CT26 cells expressing Cebpb -oe and EV control were injected subcutaneously into immunocompetent BALB/c mice ( n = 4; representative of 3 independent experiments, top) and immunodeficient BALB/c nude mice ( n = 5; single experiment, bottom). (B) Subcutaneous tumors from EV and Cebpb -oe CT26 cells injected into BALB/c mice were collected approximately 21 days post-inoculation. The percentages of CD4 + and CD8 + cells among CD45 + cells, CTLA-4 + cells among CD4 + and CD8 + cells, Foxp3 + CTLA-4 + and Foxp3 − CTLA-4 + cells among CD4 + cells, and GzmB + and IFN-γ + cells among CD8 + cells were compared by flow cytometry. (C) Mouse splenic T cells isolated from BALB/c mice were activated with anti-CD3ε and <t>anti-CD28,</t> then co-cultured with EV or Cebpb -oe CT26 cells for 72 h. The culture ratio of T cells to CT26 cells is indicated. Flow cytometry was used to analyze CTLA-4 + and Foxp3 + levels among CD4 + cells, as well as CTLA-4 + , PD-1 + , GzmB + , and IFN-γ levels among CD8 + cells. Representative histograms of CTLA-4 + expression in CD4 + T are presented. (D) mRNA expression of immune checkpoint genes in Jurkat (left) and EL4 cells (right) after co-culture with indicated cells, measured by real-time PCR. (E) Proliferation analysis of CFSE-labeled, activated mouse splenic T cells co-cultured with indicated cells for 72 h. CFSE dilution in CD4 + T and CD8 + T cells were assessed by flow cytometry and presented as histograms (representative of 2 independent experiments). (F) Transwell migration assay of mouse splenic T cells (left) and EL4 (right) cultured for 24 h in CM from Cebpb -oe or EV CT26 cells or in fresh media, in the presence of CXCL12 (200 ng/ml). (G) Tumor growth curves of BALB/c mice bearing Cebpb -oe CT26 tumors treated with isotype control IgG, anti-PD-1, anti-CTLA-4, or the combination ( n = 5 per group). Tumor volumes are shown as mean ± SD; statistical comparisons were made using 2-tailed Student’s t tests based on the final tumor volume. Bar graphs represent the mean ± SD; each dot represents an independent biological replicate. P values were calculated using 2-tailed Student’s t tests. Abbreviations: CEBPB , CCAAT enhancer binding protein beta; Cebpb -oe, Cebpb -overexpression; CFSE, carboxyfluorescein succinimidyl ester; CM, conditioned media; CTLA-4, cytotoxic T-lymphocyte associated protein 4; CXCL12, C-X-C motif chemokine ligand 12; EV, empty vector; Foxp3, forkhead box protein P3; LAG3 , lymphocyte activating 3; PD-1, programmed cell death protein 1; PDCD1 , programmed cell death 1; SD, standard deviation.
    Soluble Anti Mouse Cd28, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/soluble anti mouse cd28/product/Bio X Cell
    Average 97 stars, based on 1 article reviews
    soluble anti mouse cd28 - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    97
    Bio X Cell soluble anti cd28 antibody
    Tumor cell C/EBPβ increases CTLA-4 expression in CD4 + T cells. (A) CT26 cells expressing Cebpb -oe and EV control were injected subcutaneously into immunocompetent BALB/c mice ( n = 4; representative of 3 independent experiments, top) and immunodeficient BALB/c nude mice ( n = 5; single experiment, bottom). (B) Subcutaneous tumors from EV and Cebpb -oe CT26 cells injected into BALB/c mice were collected approximately 21 days post-inoculation. The percentages of CD4 + and CD8 + cells among CD45 + cells, CTLA-4 + cells among CD4 + and CD8 + cells, Foxp3 + CTLA-4 + and Foxp3 − CTLA-4 + cells among CD4 + cells, and GzmB + and IFN-γ + cells among CD8 + cells were compared by flow cytometry. (C) Mouse splenic T cells isolated from BALB/c mice were activated with anti-CD3ε and <t>anti-CD28,</t> then co-cultured with EV or Cebpb -oe CT26 cells for 72 h. The culture ratio of T cells to CT26 cells is indicated. Flow cytometry was used to analyze CTLA-4 + and Foxp3 + levels among CD4 + cells, as well as CTLA-4 + , PD-1 + , GzmB + , and IFN-γ levels among CD8 + cells. Representative histograms of CTLA-4 + expression in CD4 + T are presented. (D) mRNA expression of immune checkpoint genes in Jurkat (left) and EL4 cells (right) after co-culture with indicated cells, measured by real-time PCR. (E) Proliferation analysis of CFSE-labeled, activated mouse splenic T cells co-cultured with indicated cells for 72 h. CFSE dilution in CD4 + T and CD8 + T cells were assessed by flow cytometry and presented as histograms (representative of 2 independent experiments). (F) Transwell migration assay of mouse splenic T cells (left) and EL4 (right) cultured for 24 h in CM from Cebpb -oe or EV CT26 cells or in fresh media, in the presence of CXCL12 (200 ng/ml). (G) Tumor growth curves of BALB/c mice bearing Cebpb -oe CT26 tumors treated with isotype control IgG, anti-PD-1, anti-CTLA-4, or the combination ( n = 5 per group). Tumor volumes are shown as mean ± SD; statistical comparisons were made using 2-tailed Student’s t tests based on the final tumor volume. Bar graphs represent the mean ± SD; each dot represents an independent biological replicate. P values were calculated using 2-tailed Student’s t tests. Abbreviations: CEBPB , CCAAT enhancer binding protein beta; Cebpb -oe, Cebpb -overexpression; CFSE, carboxyfluorescein succinimidyl ester; CM, conditioned media; CTLA-4, cytotoxic T-lymphocyte associated protein 4; CXCL12, C-X-C motif chemokine ligand 12; EV, empty vector; Foxp3, forkhead box protein P3; LAG3 , lymphocyte activating 3; PD-1, programmed cell death protein 1; PDCD1 , programmed cell death 1; SD, standard deviation.
    Soluble Anti Cd28 Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/soluble anti cd28 antibody/product/Bio X Cell
    Average 97 stars, based on 1 article reviews
    soluble anti cd28 antibody - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    Image Search Results


    Tumor cell C/EBPβ increases CTLA-4 expression in CD4 + T cells. (A) CT26 cells expressing Cebpb -oe and EV control were injected subcutaneously into immunocompetent BALB/c mice ( n = 4; representative of 3 independent experiments, top) and immunodeficient BALB/c nude mice ( n = 5; single experiment, bottom). (B) Subcutaneous tumors from EV and Cebpb -oe CT26 cells injected into BALB/c mice were collected approximately 21 days post-inoculation. The percentages of CD4 + and CD8 + cells among CD45 + cells, CTLA-4 + cells among CD4 + and CD8 + cells, Foxp3 + CTLA-4 + and Foxp3 − CTLA-4 + cells among CD4 + cells, and GzmB + and IFN-γ + cells among CD8 + cells were compared by flow cytometry. (C) Mouse splenic T cells isolated from BALB/c mice were activated with anti-CD3ε and anti-CD28, then co-cultured with EV or Cebpb -oe CT26 cells for 72 h. The culture ratio of T cells to CT26 cells is indicated. Flow cytometry was used to analyze CTLA-4 + and Foxp3 + levels among CD4 + cells, as well as CTLA-4 + , PD-1 + , GzmB + , and IFN-γ levels among CD8 + cells. Representative histograms of CTLA-4 + expression in CD4 + T are presented. (D) mRNA expression of immune checkpoint genes in Jurkat (left) and EL4 cells (right) after co-culture with indicated cells, measured by real-time PCR. (E) Proliferation analysis of CFSE-labeled, activated mouse splenic T cells co-cultured with indicated cells for 72 h. CFSE dilution in CD4 + T and CD8 + T cells were assessed by flow cytometry and presented as histograms (representative of 2 independent experiments). (F) Transwell migration assay of mouse splenic T cells (left) and EL4 (right) cultured for 24 h in CM from Cebpb -oe or EV CT26 cells or in fresh media, in the presence of CXCL12 (200 ng/ml). (G) Tumor growth curves of BALB/c mice bearing Cebpb -oe CT26 tumors treated with isotype control IgG, anti-PD-1, anti-CTLA-4, or the combination ( n = 5 per group). Tumor volumes are shown as mean ± SD; statistical comparisons were made using 2-tailed Student’s t tests based on the final tumor volume. Bar graphs represent the mean ± SD; each dot represents an independent biological replicate. P values were calculated using 2-tailed Student’s t tests. Abbreviations: CEBPB , CCAAT enhancer binding protein beta; Cebpb -oe, Cebpb -overexpression; CFSE, carboxyfluorescein succinimidyl ester; CM, conditioned media; CTLA-4, cytotoxic T-lymphocyte associated protein 4; CXCL12, C-X-C motif chemokine ligand 12; EV, empty vector; Foxp3, forkhead box protein P3; LAG3 , lymphocyte activating 3; PD-1, programmed cell death protein 1; PDCD1 , programmed cell death 1; SD, standard deviation.

    Journal: Cancer Communications

    Article Title: CEBPB Expression in Tumor Cells Drives Immune Evasion in Colorectal Cancer via CTLA4 Up-regulation in T Cells

    doi: 10.34133/cancomm.0013

    Figure Lengend Snippet: Tumor cell C/EBPβ increases CTLA-4 expression in CD4 + T cells. (A) CT26 cells expressing Cebpb -oe and EV control were injected subcutaneously into immunocompetent BALB/c mice ( n = 4; representative of 3 independent experiments, top) and immunodeficient BALB/c nude mice ( n = 5; single experiment, bottom). (B) Subcutaneous tumors from EV and Cebpb -oe CT26 cells injected into BALB/c mice were collected approximately 21 days post-inoculation. The percentages of CD4 + and CD8 + cells among CD45 + cells, CTLA-4 + cells among CD4 + and CD8 + cells, Foxp3 + CTLA-4 + and Foxp3 − CTLA-4 + cells among CD4 + cells, and GzmB + and IFN-γ + cells among CD8 + cells were compared by flow cytometry. (C) Mouse splenic T cells isolated from BALB/c mice were activated with anti-CD3ε and anti-CD28, then co-cultured with EV or Cebpb -oe CT26 cells for 72 h. The culture ratio of T cells to CT26 cells is indicated. Flow cytometry was used to analyze CTLA-4 + and Foxp3 + levels among CD4 + cells, as well as CTLA-4 + , PD-1 + , GzmB + , and IFN-γ levels among CD8 + cells. Representative histograms of CTLA-4 + expression in CD4 + T are presented. (D) mRNA expression of immune checkpoint genes in Jurkat (left) and EL4 cells (right) after co-culture with indicated cells, measured by real-time PCR. (E) Proliferation analysis of CFSE-labeled, activated mouse splenic T cells co-cultured with indicated cells for 72 h. CFSE dilution in CD4 + T and CD8 + T cells were assessed by flow cytometry and presented as histograms (representative of 2 independent experiments). (F) Transwell migration assay of mouse splenic T cells (left) and EL4 (right) cultured for 24 h in CM from Cebpb -oe or EV CT26 cells or in fresh media, in the presence of CXCL12 (200 ng/ml). (G) Tumor growth curves of BALB/c mice bearing Cebpb -oe CT26 tumors treated with isotype control IgG, anti-PD-1, anti-CTLA-4, or the combination ( n = 5 per group). Tumor volumes are shown as mean ± SD; statistical comparisons were made using 2-tailed Student’s t tests based on the final tumor volume. Bar graphs represent the mean ± SD; each dot represents an independent biological replicate. P values were calculated using 2-tailed Student’s t tests. Abbreviations: CEBPB , CCAAT enhancer binding protein beta; Cebpb -oe, Cebpb -overexpression; CFSE, carboxyfluorescein succinimidyl ester; CM, conditioned media; CTLA-4, cytotoxic T-lymphocyte associated protein 4; CXCL12, C-X-C motif chemokine ligand 12; EV, empty vector; Foxp3, forkhead box protein P3; LAG3 , lymphocyte activating 3; PD-1, programmed cell death protein 1; PDCD1 , programmed cell death 1; SD, standard deviation.

    Article Snippet: Before co-culturing with cancer cells, isolated T cells (1 × 10 6 ) were pre-incubated with plate-coated anti-mouse CD3ε (1.25 μg/ml; BE0001-1, Bio X Cell) and soluble anti-mouse CD28 (1 μg/ml; BE0015-1, Bio X Cell) for polyclonal T cell activation, and seeded at a density of (2 × 10 5 ) cells on 96-well plates.

    Techniques: Expressing, Control, Injection, Flow Cytometry, Isolation, Cell Culture, Co-Culture Assay, Real-time Polymerase Chain Reaction, Labeling, Transwell Migration Assay, Binding Assay, Over Expression, Plasmid Preparation, Standard Deviation